Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck
Clinical trial NCT02769520 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02769520
- Sponsor
- Assuntina G. Sacco, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-06
- Primary completion
- 2026-04-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.